EmblemHealth's board asked Karen Ignagni to resume the CEO role after the previous CEO retired.
“I've been asked by the board just a few days ago to reassume the CEO position here at EmblemHealth. Our CEO has just retired.”

3 Oct 2026 · 22m · Karen Ignagni, Elizabeth Casalo · 20 quoted facts
Karen Ignagni, returning as CEO of EmblemHealth, argues that health plans can improve affordability and member outcomes through modern technology, care management, value-based payment and cross-industry collaboration. She also argues that the real drivers of health costs, especially hospital and drug prices, are being politically avoided, and that policy changes such as Medicaid work requirements and expired subsidies risk pushing working families out of coverage.
The central tension is between what plans can do on their own and what policy and pricing choices outside their control will do. Ignagni describes a modernized plan ready for 2027 interoperability rules and equipped with AI-driven, personalized care. Yet she warns that new Medicaid requirements, lapsed ACA subsidies and rising living costs could cause coverage losses, bad debt and costlier emergency care.
Ignagni says that after 9/11, when Empire's offices in the towers were lost, the industry joined forces to help pay claims and support its CEO. She says this taught her the value of collaboration that she carried from AHIP to EmblemHealth.
Because exemption rules are unclear (for example, cancer is not an automatic exemption), EmblemHealth needs government affairs, communications and customer service teams working together. The work is continuous, since members need up-to-date guidance on renewals and required information.
Ignagni says uninsured people with chronic conditions lose prevention, drugs and care management, and delay care until a crisis reaches the emergency room. That, she argues, creates more bad debt and raises costs for everyone.
Ignagni cites a Yale study in JAMA saying unit costs fueled 90% of expenditure growth from 2011 to 2024. She says hospitals priced above 400% of Medicare and consolidated systems with anti-competitive contract terms push premiums up.
Ignagni proposes that hospitals and pharmaceutical companies report something like the insurers' medical loss ratio, which shows what share of revenue goes to care versus administration and profit. She says this would let the public see what is really driving costs.
She says the board asked her a few days before the recording to resume the CEO role after the previous CEO retired. She had been executive chair after serving as CEO for 18 months.
Ignagni cites a Yale study published in JAMA saying that rising unit prices drove 90% of the growth in spending from 2011 to 2024. She points to high hospital prices, hospital consolidation and drug company profits rather than insurer administrative costs.
Ignagni says the rules are new and unclear about who gets exemptions, and she fears people will lose coverage even though they are working or in school. She expects problems for working families and for state governments, and she says EmblemHealth is running a coordinated effort to help members understand and meet the requirements.
She says they tend to skip preventive care and medications and wait until a crisis, entering the system through the emergency room. This creates more unpaid bills (bad debt) and raises costs for hospitals and everyone else.
Ignagni says the plan modernized its technology to match large competitors, including in customer service and care management. She says AI and predictive modeling help identify people at risk of chronic disease and support people with conditions like congestive heart disease on an individual basis.
Stated by the speakers. Each quote matches the transcript, which shows what was said, not that it is true.
EmblemHealth's board asked Karen Ignagni to resume the CEO role after the previous CEO retired.
“I've been asked by the board just a few days ago to reassume the CEO position here at EmblemHealth. Our CEO has just retired.”
Karen Ignagni served as CEO of EmblemHealth for 18 months and then as executive chair before returning to CEO.
“I was executive chair after being CEO for 18 months, so I never left.”
EmblemHealth is a not-for-profit community mission health plan based in New York City.
“We are a very important not-for-profit community mission plan in New York City. That's where we're domiciled.”
Karen Ignagni says EmblemHealth was the first plan in New York State to receive NCQA equity accreditation for all lines of business.
“We're the first plan in New York State to have NCQA accreditation, equity accreditation for all lines of business.”
Empire, the Blue Cross Blue Shield plan in New York City, lost employees and its workplace in the September 11 attacks.
“they were in the tower. They lost, sadly, people, and they lost their place of work.”
After 9/11, AHIP mobilized health plans to help pay Empire's claims and support its CEO, Mike Stocker.
“we mobilized the industry to collaborate and help pay claims and help give the CEO there, Mike Stocker, Dr. Stocker, support in a variety of ways.”
During Ignagni's AHIP tenure, the industry worked with President George W. Bush on Medicare Part D and with President Barack Obama on the Affordable Care Act.
“working together with President Bush on Part D and being solution providers and then President Obama on the ACA”
EmblemHealth operates 15 neighborhood care centers open to anyone, offering help with food, transportation and housing.
“We have 15 what we call neighborhood care centers, which anyone in our communities, you don't have to be a member of ours, can walk in, get help with food, with transportation, with housing”
Parts of a federal interoperability rule are set to take effect in 2027, requiring new data interfaces.
“other parts of the interoperability rule coming into play in 2027.”
Karen Ignagni says that under the Medicaid work requirements, a person with cancer does not automatically get an exemption, which she finds puzzling.
“on work requirements, if you have cancer, you don't have an automatic exemption. That's a head scratcher to me.”
The Trump administration announced $500 checks to nearly 1 million Americans in states using the federal exchange, according to host Elizabeth Casalo.
“the Trump administration recently announced it would send $500 checks to nearly 1 million Americans and states using the federal exchange.”
The ACA enhanced subsidies expired roughly a year before this recording, according to the host.
“we are approaching one year since ACA enhanced subsidies expired”
New York operates its own state insurance exchange and is therefore excluded from the federal-exchange $500 checks.
“Yeah, we have a state exchange, right.”
Karen Ignagni says ACA subsidies went largely to working families, many of them healthcare workers in nursing homes, home health and FQHCs.
“The subsidies were, and I'm not so sure it seemed to happen so quickly for people to really document this. But for those of us in the health plan community, we know the subsidies were going to working families.”
Karen Ignagni cites a Yale study published in JAMA examining what drives U.S. health care costs.
“a very compelling study that I saw just a few days ago from Yale. It was in JAMA about what's really driving costs.”
According to the JAMA study Ignagni cites, unit costs accounted for 90 percent of growth in health expenditures from 2011 to 2024.
“Unit costs, according to the study in JAMA, just published, has fueled 90 % of the growth in expenditures from 2011 to 2024.”
Karen Ignagni says some hospitals charge over 400 percent of Medicare rates and that consolidated hospitals use anti-competitive contract provisions.
“We have hospitals that are over 400 % of Medicare. We have hospitals that have been highly consolidated and have anti-competitive contract provisions”
Karen Ignagni says pharmaceutical companies earn profits of 20 to 25 percent and do not put those resources mainly into drug development.
“the data show that they're making profits in the 20 to 25% range. They're not allocating these resources to development of drugs.”
Karen Ignagni proposes applying a medical loss ratio-style disclosure to hospitals and drug companies to show administrative costs and profits.
“we have an MLR in our industry. If we had an MLR for hospitals and pharmaceutical companies, the public could clearly see what the administrative costs are”
Becker's fifth annual Fall Payer Issues Roundtable was advertised as drawing more than 500 executives and over 70 speakers on November 2 and 3 at the Swissôtel Chicago.
“Becker's fifth annual Fall Payer Issues Roundtable convenes more than 500 executive-level attendees and 70-plus speakers November 2nd and 3rd at the Swiss Hotel Chicago.”
Ignagni explains why she resumed the CEO role and how the company has modernized its technology and customer service and earned equity accreditation.
“it was a turnaround situation”
She describes what she learned leading AHIP, from 9/11 claims support to working with Presidents Bush and Obama, and how she applied it at EmblemHealth.
“the power of collaboration within an industry for positive change”
EmblemHealth's community centers offer help with food, transportation and housing to anyone, reflecting its community mission.
“anyone in our communities, you don't have to be a member of ours, can walk in”
Ignagni says modernized technology means the plan is prepared for new data-sharing requirements.
“we are ready to share data”
She explains the uncertainty in exemptions and how plans must help members navigate a continuous, complex process.
“It's a full court press here, because you have to look at it systematically.”
She discusses $500 checks, household affordability pressures and the consequences of people leaving coverage, including healthcare workers.
“It'll be the kitchen table test for many families.”
Ignagni cites a JAMA study on unit prices and calls for transparency from hospitals and drugmakers.
“Unit costs, according to the study in JAMA, just published, has fueled 90 % of the growth in expenditures from 2011 to 2024.”
She describes using predictive tools for personalized care and urges plans to put their own houses in order.
“everybody wants to be treated as an N of one”
GLP wants Medicare Advantage headwinds, a Medicaid landscape that looks different every quarter. Payer leadership right now means making durable decisions in an environment that keeps moving, and the organizations pulling ahead are the ones that stopped waiting for stability before acting. Becker's fifth annual Fall Payer Issues Roundtable convenes more than 500 executive-level attendees and 70-plus speakers November 2nd and 3rd at the Swiss Hotel Chicago. Two days of senior level dialogue on affordability, benefit design, value-based care, and the strategies shaping how care gets financed and delivered.
Featuring a celebrity keynote from Pro Football Hall of Famer, Emmett Smith. Agenda and registration at beckerspayer.com. Click events in the upper right.
Hi, everyone. This is Elizabeth Casalo with the Becker's Payer Issues podcast. I'm thrilled today to be joined by Karen Ignagni, CEO of EmblemHealth. Karen, thank you so much for chatting with us today.
Thanks, Liz. Happy to do it.
Thanks, Karen. So before we jump in, I would love to hear a little bit more about yourself, your healthcare career background, and also your current role at EmblemHealth, which there's been a very recent exciting update. So excited to hear what you have to say there.
Thank you so much. I've been asked by the board just a few days ago to reassume the CEO position here at EmblemHealth. Our CEO has just retired. And it was an honor to say yes, I love this company. We have transformed this company and we're growing now. So we have modernized every aspect of it. So it's a pleasure to come in at this stage now. I was executive chair after being CEO for 18 months, so I never left.
But now it's wonderful to be working with the operating team again and getting back into all aspects of what we're doing.
So just to kind of tease that out a little bit more, with your reassumption of the CEO role, what is different now than prior? I would love to hear. I know it's been a few days since it's been announced.
Oh, I can answer that question very quickly. When I came to EmblemHealth, it was a turnaround situation. And I'm so grateful and many of the people are here who went through that with me. We are a very important not-for-profit community mission plan in New York City. That's where we're domiciled. And bringing this plan back, which meant modernizing the technology, modernizing our customer service, making sure that we can compete with all of the large players.
So we have technology now that's on par with all of them. We have all of the bells and whistles that you would expect with respect to customer service, with respect to AI, with respect to every aspect of our care management and other medical enterprises. So we feel really excited about where we are. We feel excited about growth. And we feel equally excited about what we are doing in the community. We're the first plan in New York State to have NCQA accreditation, equity accreditation for all lines of business.
And that's just been renewed. So we're very proud of that. It's a very important part of what we do.
So you've previously led AHIP prior to your tenure at EmblemHealth. So I would love to hear what's the biggest thing you underestimated in that role that became more clear, especially in that turnaround phase of things as you jumped into EmblemHealth?
It's actually a really good question and one I thought about quite a lot throughout my experience at AHIP. I think coming into the role, we were, and at that time it was very similar to coming into Emblem, we were building an organization. And I didn't quite understand the power of collaboration within an industry for positive change. And indeed, we were quickly embedded in a range of challenges at AHIP and mobilizing the industry to work together to make people's lives better, to solve problems.
I think I hadn't quite, going into that role, understood the power of that. I'll give you an example. During 9-11, the leader, it was then called Empire, which is the Blue Cross Bushio plan in New York City. They were in the tower. They lost, sadly, people, and they lost their place of work. So we mobilized the industry to collaborate and help pay claims and help give the CEO there, Mike Stocker, Dr. Stocker, support in a variety of ways.
And you wouldn't think about that from a health plan perspective, but everybody stood up and collaborated from small plan to large plan in this area. We also had a history of helping and partnering with the CDC, with NIH, on some of the infectious disease and SARS issues that occurred, kind of a pre-COVID sort of thing. And that worked very, very well and very important. And then working together with President Bush on Part D and being solution providers and then President Obama on the ACA and coming to the table with solutions, with thoughts, working with partners and other industries, just A, learning how to do that and then executing it and really seeing the power of an industry working together
to solve problems was something that I took away. from AHIP with me. And we've tried to do quite a lot of that here. We have been a leader in simplifying prior authorizations, for example. We've been a leader in value-based payments and all shapes and sizes we can do. Our technology allows us to customize and meet physicians and hospitals where they are. So wherever they are on the continuum, we can offer solutions to collaborate. And then we were early into the issue of social determinants of care because of our community mission.
We have 15 what we call neighborhood care centers, which anyone in our communities, you don't have to be a member of ours, can walk in, get help with food, with transportation, with housing, take a free class, ask a question, just generally get help and find people who are there to support the community. But that really gave us an understanding of the importance of addressing social determinants of care as we dealt with inequities and as we dealt with people who had been underserved.
Our centers are in some of the most underserved parts of New York. And so we're very proud to have contributed, again, making people's lives better through those centers through our team. And they truly, every time I go to one of these centers, I get goosebumps watching our teamwork and how they interact with the community and community-based organizations. So I took those lessons with me from AHIP. I also want to follow up on some of the
policy points and administration relationships you touched on earlier. I'm curious, you know, other parts of the interoperability rule coming into play in 2027. So how are you feeling heading into 2027 with some of those interfaces that are now going to be required? Well, if we hadn't
modernized our technology, I wouldn't be sleeping a wink, but we have. So, and our leader here, our chief operating officer and his team have done just an outstanding job. So we are ready to share data we are ready to do, what is being required in the new regulations. And again, we can seamlessly do this now. If you had asked this question, and if those requirements had existed 10 years ago, I would not have given you the confident answer that I just gave you.
And another big policy item coming into play is going to be the Medicaid work requirements and more frequent eligibility checks for the expansion population. So you talked a little bit about the community centers, but I'm curious, how is EmblemHealth preparing members for these changes?
It's a full court press here, because you have to look at it systematically. We have had a lot, and other health plans, of course, all the other health plans have had lots of experience with recertification. But this is entirely different because there is an entirely new structure now that's imposed. And it's very, very unclear as to which individuals can get exemptions. For example, on work requirements, if you have cancer, you don't have an automatic exemption. That's a head scratcher to me.
And there are many other examples of that sort. So we have to make sure we help our members understand what the requirements are, where there may be opportunities quite importantly for them because they fall into various categories for exemptions, when they are going to be coming up for renewal, what kind of information they have to provide. So again, it broadens out this role of a health plan. It moves us into a social support mechanism and social support organization to provide this support, to provide this information and provide a helping hand to our members.
That means not only do you have to have the technology that helps give people warning, you have to have the information up to the minute of what are the regs say, what are the requirements, et cetera, and make sure that's always being refreshed. So So you need spectacular government affairs people who are keeping in touch with that. And then you need communications people and customer service people to convey all this. And it's not one and done.
It's a continuous process. So when I say it's a full court press, there are a number of towers within our organization that not only are working on these issues, but working together. because unless they work together, we will not be as effective as we need to be for our members.
Do you have concerns about how state governments are prepared or how prepared they really are for these requirements coming in the new year?
I have concerns about how everyone is prepared. I think that it is very, very difficult to sort through this. it hasn't been done. I think that the question is when folks see people falling through the cracks, which will definitely happen, it happens always with something that's new. Will that be a spark that causes people to really take another look, reevaluate, and really think about what are we asking for? For what purpose? Obviously, everyone supports this concept of fraud detection and preventing that.
But if we are imposing such requirements that you're discouraging people from participating, because they're trying to take care of their families, they're trying to work, they're in school, et cetera. These are working families. Then you wonder, is the goal being achieved? Because we want to make sure that people have the healthcare access that they need. So I'm very worried about people falling out of the system. I'm worried about bad debts, which I've been worried about in terms of the subsidies going away as well.
And I think we're going to see a number of people falling out. And I think that's going to cause quite a lot of consternation, not only at the local level, but at the state level. And it'll flow up to the national level as we head into a presidential election. So some of what you were just saying
feeds into another thing I wanted to ask about. You know, we are approaching one year since ACA enhanced subsidies expired and the Trump administration recently announced it would send $500 checks to nearly 1 million Americans and states using the federal exchange. So while that does exclude New York, you know, I am curious. Because we have a state exchange,
just so everybody knows. Yeah, we have a state exchange, right.
But I am curious with your AHIP background, what is your reaction to that given the subsidy
expiration? I think that the fact that the administration is recognizing that people need help is important. Now the question is whether that is adequate, whether it will allow people to continue the coverage that they need, and whether or not, given the high price of food, the high price of gas, the high price of health care, that it will actually go to help them with their healthcare expenditures. I don't know the answer to that right now. It'll be the kitchen table test for many families.
And we know people need coverage. We know affordability is number one on their minds. But we also know that going to the grocery store is far more expensive today and continuing to be more expensive. We know gas is more expensive, as you know, seems by the hour. So I'm very worried about how people will afford to stay in the system. And that has significant repercussions if they can't. That means prevention goes away. That means if I have asthma, if I have chronic heart disease, if I have, name your disease, that I don't get the care management, I don't get the drugs, I don't get the support, I need to manage that.
So the only alternative, if I'm uncovered, is to ignore things because I can't afford it and wait till things get to a critical stage and enter the doors of the healthcare system through the hospital emergency room. That creates more bad debts, that makes things more expensive for everyone. It's a burden on our hospitals, on our hospital workers. And it makes no sense because it turns upside down everything we know about the value of early intervention.
I was just reading another article about how even some healthcare workers are opting out of
coverage because they can't afford it. Well, that is the subsidy story. The subsidies were, and I'm not so sure it seemed to happen so quickly for people to really document this. But for those of us in the health plan community, we know the subsidies were going to working families. Many of them are healthcare workers. They work in nursing homes. They work in home health. They work in FQHCs. They work in certain hospitals around the country. For those workers to lose health care coverage, we are talking about working families.
We're also having a conversation macroly in our country about how we encourage growth. Working families are the key to productivity and growth throughout our economy. So to yank health insurance from those individuals, I think is penny wise and pound foolish from an economic perspective. And it's awful from a healthcare perspective, because those are the very workers you need to stay healthy so they can do their jobs. They are helping the rest of us.
On the topic of affordability, you can think about EmblemHealth, but you could also think big picture. What is the best insurer strategy you've seen to address those concerns right now?
Well, first of all, let me tell you what's not being done on affordability. People who are leaders in Congress and state government are allergic to the issue of affordability because they don't want to confront the politics. And I'm going to give you one example of something, a very compelling study that I saw just a few days ago from Yale. It was in JAMA about what's really driving costs. And they actually said what we know in the health care community and the health plan community, our admin is coming down.
Meanwhile, costs, unit costs are going up. Unit costs, according to the study in JAMA, just published, has fueled 90 % of the growth in expenditures from 2011 to 2024. Members of Congress and in states don't want to confront the policy issues surrounding higher and higher hospital costs. We have hospitals that are over 400 % of Medicare. We have hospitals that have been highly consolidated and have anti-competitive contract provisions, which is causing a growth in premiums.
There is a reluctance to confront that because of the politics. Then we get to the pharmaceutical companies. They basically say, oh, it's the health plan's fault. Well, the data show that they're making profits in the 20 to 25% range. They're not allocating these resources to development of drugs. And so one of the things, Liz, I think a simple thing, we have an MLR in our industry. If we had an MLR for hospitals and pharmaceutical companies, the public could clearly see what the administrative costs are, number one, what are profits, and have a conversation about what's really driving costs.
because we are not having that conversation today at all. So when you ask me, what are the productive strategies? From a health plan perspective, we will continue to do a number of things to try to bend the curve with care management, value-based payments. We will continue to move upstream on preventive care and wellness and making sure that people who have chronic conditions are being managed so that we keep their costs from their perspective down, but we keep them out of the hospital and we keep them as healthy as we can.
That's our role. And we're doing a number of things as are a number of health plans to do that. And we're using AI in very interesting areas to really help support an individual who has congestive heart disease or who has another type of chronic condition, because everybody wants to be treated as an N of one. You know, we've had this language in the healthcare community, population health. People don't want to be a population. They want to be an N of one.
And now we have the tools to go upstream to do the predictive modeling that's necessary to say, I may be at risk of a certain chronic disease to reach out, to help, to support, and to help manage me and anybody else in that category. So those are the really exciting things that are going on in the health plan community because we touch people in every encounter in the healthcare system. No other industry is in that position.
So now we have the tools that allow us to customize treatment, to target treatment, and to really support people the way they want to be supported. We have the tools to make people's lives better, which is really exciting. Do you have any final thoughts for industry leaders as we wrap up? I think that we have a lot that we need to do if we're going to be in the congressional arena, the state arena, and talk about affordability and what others should do.
Then we have an obligation to make sure our own houses are in order, that we're doing things to take down abrasion for individuals. We're cleaning up practices and we're doing as much as we can to simplify processes. And there's a whole list of things that could be done. Maybe that's our next
podcast. Well, thank you so much, Karen, for taking the time today. I appreciate it. And to our listeners, if you'd like to hear more podcasts from Becker's Healthcare, you can visit beckershospitalreview.com. Thanks again, Karen. Thank you. Thank you.